【国庆70周年献礼】最美奋斗者白先宏奋斗新时代！

(Summary description)

Information

今年是新中国成立70周年，新时代是奋斗者的时代,百泰生物在北京市经济技术开发区成立近20年来，离不开每一位怀揣梦想的奋斗者与祖国同呼吸、共命运。

作为创新型发展起来的民族医药企业，百泰生物董事长白先宏当选为北京市经济技术开发区“最美奋斗者”亦庄榜样，用自己每时每刻的实干实绩为祖国70华诞献礼！

Previous: 白先宏董事长受邀参加第十一届中古政府间科技合作混委会

Previous: 白先宏董事长受邀参加第十一届中古政府间科技合作混委会



Home
About Us 
-  About Us
- About Us
- Core Team
- Development History
- Corporate Culture
About Us
BPL is a high-tech China-Cuba joint venture among first group engaged in the development, production and sales of monoclonal antibodies in China.
S&T 
-  S&T
- Research Areas
- Technology Platforms
S&T
The world's leading humanized monoclonal antibody preparation process and large-scale continuous mammalian cells culture technology.
Research and Development 
-  Research and Development
- Marketed Products
- R&D Products
- R&D Pipeline
- Academic Progress
Research and Development
BPL developed the first humanized monoclonal antibody drug Nimotuzumab (trade name: Taixinsheng) for the treatment of malignant tumors in China.
Media Center 
-  Media Center
- Press Releases
- Media Reports
Media Center
Present industry-related media reports and various company activities and trends.
Join Us 
-  Join Us
- Post-Doctoral Center
Join Us
We sincerely welcome talents from all walks of life to join BPL, qualified as post-doctoral research workstation with diversified professional positions.
Contact Us 
-  Contact Us
- Contact Us
Contact Us
Counseling Hotline: 400-659-2330
TEL: 010-50571020